The findings may help in the development of new diagnostics for the condition, as well as inform research into long COVID, which can have similar symptoms.

News items for the week of Sept. 19, 2022. 

Biosynex currently holds 25 percent of the share capital and voting rights of Theradiag and offered to purchase the firm for €2.30 per share.

The VALID Act could still be attached to other legislation this year, but the user fee bill had been widely viewed as an ideal vehicle for its passage.

Bionano Laboratories will offer services to clinical customers seeking to implement OGM for routine diagnostic use.

Caris' molecular profiling services will be available directly on Flatiron's OncoEMR platform for electronic health record management.

In a report released on Wednesday, the office critiqued the FDA's pandemic performance and recommended new approaches.

Pathologists will be able to adopt Paige's applications, such as its artificial intelligence-based software, with OptraScan's digital pathology scanners.

The PerkinElmer subsidiary said its T-Cell Select reagent kit reduces hands-on lab work and cost and simplifies blood sample storage.

Cosmos will have exclusive distribution rights for Greece and Cyprus with the opportunity to nonexclusively distribute the tests across Europe.